1. "Pediatrics, Department of"
Formats
  1. Journal Article (2874)
  2. Meeting Abstract (1908)
  3. Review (135)
  4. Book Section (123)
  5. Editorial (61)
  6. Conference Paper (53)
  7. Research Letter (33)
  8. Correspondence (25)
  9. Guidelines (23)
  10. Miscellaneous (11)
  11. Book Whole (4)
Groups
  1. Pediatrics, Department of (5250)
  2. Tow Center for Developmental Oncology (TCDO) (2073)
  3. GSK Faculty (1984)
  4. Center for Hematologic Malignancies (1906)
  5. Stem Cell Transplantation and Cellular Therapy Service (1636)
  6. Department of Medicine (1584)

More Groups

People
  1. Richard O'Reilly (748)
  2. Nai-Kong Cheung (648)
  3. Nancy Kernan (512)
  4. Michael La Quaglia (411)
  5. David Abramson (388)
  6. Ira Dunkel (371)

More People

Years
  1. 2025 (91)
  2. 2024 (231)
  3. 2023 (272)
  4. 2022 (332)
  5. 2021 (278)
  6. 2020 (323)

More Years

Publications
  1. Blood (608)
  2. Journal of Clinical Oncology (430)
  3. Pediatric Blood and Cancer (416)
  4. Biology of Blood and Marrow Transplantation (265)
  5. Neuro-Oncology (235)
  6. Cancer Research (129)

More Publications

Publishers
  1. American Society of Hematology (663)
  2. Elsevier Inc. (658)
  3. American Society of Clinical Oncology (463)
  4. Wiley Periodicals, Inc (430)
  5. Oxford University Press (338)
  6. American Association for Cancer Research (317)

More Publishers

Results (5250)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of exercise on psychological burden in adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS)
    Meeting Abstract

    Tonorezos, E. S.; Ford, J.; Wang, L.; Ness, K. K.; Yasui, Y.; Leisenring, W. M.; Sklar, C. A.; Robison, L. L.; Oeffinger, K. C.; Nathan, P. C.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Prospective Registry of Multiplex Testing (PROMPT): Feasible and sustainable
    Meeting Abstract

    Symecko, H.; Brower, J.; Drogan, C.; Harstad, T.; Salo-Mullen, E. E.; Pradhan, N.; Hamilton, J.; BalmanĖƒa, J.; Walsh, M. F.; Couch, F.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • In vitro and xenograft anti-tumor activity, target modulation and drug synergy studies of PV-10 against refractory pediatric solid tumors
    Meeting Abstract

    Swift, L.; Zhang, C.; Trippett, T. M.; Narendran, A.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Local drug activation technology to make cytotoxics safer for localized solid tumors
    Meeting Abstract

    Srinivasan, S.; Yee, N.; Dela Cruz, F.; Kung, A.; Gaviria, E.; Miller, E.; Royzen, M.; Oneto, J. M. M.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Using patient-reported outcomes measures to tailor care for complex cancer survivors: A feasibility study of HN-STAR
    Meeting Abstract

    Salz, T.; Salner, A. L.; Raghunathan, N. J.; McCabe, M. S.; Dornelas, E.; Finitsis, D.; Corcoran, S.; Fortier, E.; Weber, R.; Tin, A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Preliminary report of a multicenter, phase 2 study of bevacizumab in children and adults with neurofibromatosis 2 and progressive vestibular schwannomas: An NF Clinical Trials Consortium study
    Meeting Abstract

    Plotkin, S. R.; Tonsgard, J. H.; Ullrich, N. J.; Allen, J. C.; Rosser, T. L.; Campian, J. L.; Clapp, D. W.; Fisher, M. J.; Cutter, G. R.; Korf, B. R.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Matched targeted therapy for pediatric patients with relapsed, refractory or high-risk leukemias: A report from the LEAP consortium
    Meeting Abstract

    Pikman, Y.; Tasian, S. K.; Sulis, M. L.; Blonquist, T. M.; Maloney, K. W.; McNeer, J. L.; Pauly, M. G.; Shukla, N. N.; Tyner, J.; Cole, P. D.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Risk-adapted therapy for pediatric Hodgkin lymphoma (HL) results in lower risk of late effects: A report from the Childhood Cancer Survivor Study (CCSS)
    Meeting Abstract

    Oeffinger, K. C.; Stratton, K.; Hudson, M. M.; Leisenring, W.; Howell, R. M.; Wolden, S. L.; Constine, L. S.; Diller, L.; Henderson, T. O.; Sklar, C. A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • The addition of cycles of irinotecan/temozolomide (i/T) to cycles of vincristine, doxorubicin, cyclophosphamide (VDC) and cycles of ifosfamide, etoposide (IE) for the treatment of Ewing sarcoma (ES)
    Meeting Abstract

    Meyers, P. A.; Ambati, S. R.; Slotkin, E. K.; Dela Cruz, F.; Wexler, L. H.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Efficacy and safety results from a phase I/IIa study of dabrafenib in pediatric patients with BRAF V600-mutant relapsed refractory low-grade glioma
    Meeting Abstract

    Kieran, M. W.; Bouffet, E.; Broniscer, A.; Cohen, K. J.; Geoerger, B.; Hansford, J. R.; Hingorani, P.; Aerts, I.; Andre, N.; Bertozzi-Salamon, A. I.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save